Sweden· SE-20120621000020
Methylphenidate Sandoz 36 mg Depottablett
A methylphenidate product containing methylphenidate hydrochloride, registered in Sweden by Sandoz A/S. The same ATC class is registered in 18 of our 19 countries.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
Where it is registered
Methylphenidate is registered in 18 of 19 countries.
Countries holding a registration under ATC N06BA04 (methylphenidate), each read from that country’s own register.
- This record: Sweden, from Swedish Medical Products Agency (Sweden)
- 10 of them publish a price we can compare per daily dose
Methylphenidate · ATC N06BA04
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of methylphenidate costs, country by country.
Normalised to the WHO defined daily dose (30 mg), the median price runs from $0.56 in France to $1.87 in Switzerland — a ×3.4 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Methylphenidate · price per daily dose (30 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.87
- IT Italy$0.68
- US United States$0.56 (acquisition cost)
- FR France$0.56
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Methylphenidate Hydrochloride
- Manufacturer
- Sandoz A/S
- Country
- Sweden (SE)
- ATC code
- N06BA04
- ATC class
- Methylphenidate
- Defined daily dose
- 30 mg, O
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20120621000020
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
196 interactions on record for methylphenidate.
Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Methylphenidate · interactions on record
196 records
- 12 severe
- 45 moderate
- 3 minor
- 128 info
Most severe, free to view
- ProcarbazineL01XB01severe
- OzanimodL04AA38severe
- OzanimodL04AE02severe
- CocaineN01BC01severe
8 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ecf8de6a-a7a0-4555-b706-c20a86489da1 GET /v1/drugs/ecf8de6a-a7a0-4555-b706-c20a86489da1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PL",
"SmPC"
],
"se_npl_id": "20120621000020",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20120621000020",
"product_doc_link": "https://docetp.mpa.se/LMF/Methylphenidate%20Sandoz%20prolonged-release%20tablet%20SmPC_09001bee807a4ee4.pdf"
}See everything about methylphenidate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.